Advances in Malignant Lymphoma Virtual Meeting: Understanding and Improving Responses to Immunotherapy
Lymphomas are a form of blood cancer that begin in lymphocytes, also known as white blood cells. Over the...
Lymphomas are a form of blood cancer that begin in lymphocytes, also known as white blood cells. Over the...
Virtual scientific meetings have become the “new normal” in the COVID-19 era, enabling researchers to present and discuss recent...
Multiple myeloma is a cancer of antibody-producing cells—called plasma cells—that accounts for approximately 1.8 percent of new cancer cases...
The first paper to be accepted by the AACR’s latest journal, Blood Cancer Discovery, was published online last week....
During late spring and early summer, the U.S. Food and Drug Administration (FDA) approved four new molecularly targeted therapeutics—alpelisib...
Acute lymphoblastic leukemia (ALL) is an aggressive cancer of the bone marrow and the blood that develops in either...
Lymphomas are a collection of blood cancers stemming from aberrant lymphocytes, which are critical components of the immune system....
Multiple myeloma arises in immune cells called plasma cells. It is one of the most commonly diagnosed hematological malignancies...
Myeloma is the third most common blood cancer in the United States, arising in the plasma cells of the...
In a study published in the AACR’s journal Cancer Discovery in December, a team of researchers from the Perelman...